Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease

NCT00783692 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1116

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: vedolizumab
OTHER: Placebo

Sponsor

Millennium Pharmaceuticals, Inc.